Mohammad Ameen Ishqair: Blood Group Antigens as Emerging Biomarkers in Disease
Mohammad Ameen Ishqair, General and Emergency Physician at Al Madina Medical Center, shared on LinkedIn:
“I am honored to share that our research chapter, ‘Blood Group Antigens as Disease Markers: Infectious, Autoimmune and Neoplastic Associations’, has just been published Open Access with IntechOpen.
This work, co-authored with my exceptional research group: Dr. Aliaa Khalili, Dr. Amal Abo-Jheasha, and Dr. Anas Ameen, explores how blood group antigens extend beyond transfusion medicine to serve as critical biomarkers in infectious, autoimmune, and neoplastic diseases.
We integrate genomic data, molecular mechanisms, and epidemiological insights to provide a comprehensive paradigm for clinicians and researchers.
Read the full chapter on IntechOpen.”

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 31, 2026, 14:03Adil Aftab: Anticoagulation in CKD – Key Updates from the 2026 ESC Guidelines
-
Aug 31, 2026, 14:01Isa Oboirien: Why Might Factor XI Inhibition Work Differently in Stroke and ACS?
-
Aug 31, 2026, 13:55Mike Morrissey: Advancing Europe’s Cardiovascular Health Agenda at ESC Congress 2026
-
Aug 31, 2026, 13:44Penilla Gunther: Patient Voices Take Center Stage in Cardiovascular Prevention at ESC Congress 2026
-
Aug 31, 2026, 13:42Mohamed Saleh Gomaa: Master the Latest in PE Management
-
Aug 31, 2026, 13:38Lyn Kleinbach-Reilly: A New Standard for Coagulation Testing in Neonatal Care
-
Aug 31, 2026, 13:36Rafael Gomes: Can Prasugrel Replace Ticagrelor in ACS Treatment?
-
Aug 31, 2026, 05:35Does LDL Cholesterol Influence VTE Risk? – Ordo Fraterna Fibonacci
-
Aug 31, 2026, 05:19Tania Ahuja: Apixaban in Abdominal Transplant Patients